News from the healthcare data industry
Q&A With Jason Moore, PhD, Director of Cedars-Sinai’s Department of Computational Biomedicine 1-Apr-2022 12:05 PM EDT, by Cedars-Sinai Contact Patient Services Newswise — LOS ANGELES (April 1, 2022) — Cedars-Sinai’s newest department, Computational Biomedicine,...
British public found to be largely comfortable with the level of data sharing across society but is fearful about how AI is more broadly used Read More: https://www.itpro.co.uk/technology/artificial-intelligence-ai/367264/uk-government-blames-negative-media-coverage-of-ai
BELLEVUE, Wash., March 30, 2022 (GLOBE NEWSWIRE) — Truveta, the health system-led company with a vision of saving lives with data, today announced that it has obtained an ISO 27001...
MIAMI—Google Health is expanding the capabilities of its clinician-facing search tool using artificial intelligence to bring context to physicians’ clinical notes. Speaking at the ViVE 2022 conference, Paul Muret, vice president and...
Accessing compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. However, gaps between clinical trial data (CTD) and real world data (RWD) make it...
by Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI 01/24/2022 Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the...
REDMOND, Wash. and ATLANTA, Jan. 18, 2022 (GLOBE NEWSWIRE) — Truveta, the health system-led company with a vision of saving lives with data, and the Health Care business of LexisNexis...
Truveta wants to collect privacy-safe medical data from around the United States on a regular basis, making it available for researchers to sift and parse. The company is making real progress...
The pandemic has shown that de-identifying data for shared research is essential to address some of the biggest health issues. How can data fragmentation be balanced with value-based healthcare? In...
Last week Datavant submitted comments on the recently issued FDA’s guidance that helped to clarify how real world data could be made “fit for purpose” in regulatory decision-making. In our response, we celebrated and...